Staging of Pancreatic Cancer with Pulmonary Metastases

Classification and Staging

The American Joint Committee on Cancer (AJCC) defines the presence of pulmonary metastases in pancreatic cancer as automatically stage IV, regardless of the size of the primary tumor or lymph node involvement 1, 2, 3
The M1 category (distant metastases present) automatically defines stage IV, according to the TNM staging system 1, 2, 3
Pulmonary metastases are considered distant metastases, placing the patient in the M1 category, regardless of the T (tumor size/extension) or N (lymph node involvement) status 1, 2, 3, 4

The European Society for Medical Oncology (ESMO) classifies patients with distant metastases as having metastatic disease, with propagation to distant organs identified 1, 2, 3
Surgery may only be performed to relieve symptoms or problems such as biliary or intestinal obstruction, but not for curative intent 1, 2, 3

The American College of Radiology recommends the use of MD-CT scans to evaluate potential pulmonary metastases in patients with pancreatic cancer 5, 6
Abdominal ultrasound may be useful as an initial examination, while PET scans have no role in the diagnosis of pancreatic cancer but may be useful for evaluating treatment response 5, 6

It is essential to avoid confusing stage IV disease with locally advanced unresectable disease (stage III), which has no distant metastases but extensive vascular involvement 4
Accurate staging is crucial for patient management decisions, and underestimation of its importance should be avoided 4
Recognition that 80-85% of patients present with advanced disease without surgical resection options is critical for appropriate management 4